Nanjing Medlander Medical Technology Co.,Ltd. (SHSE:688273) announces a share repurchase program. Under the program, the company will repurchase up to CNY 40 million worth of its A shares. The shares will be repurchased at a price of CNY 50 per share.

The repurchased shares will be used as equity incentive. If the company will not be able fully utilize its repurchased shares within 3 years after the share repurchase implementation result and on the announcement date of the share changes, the unutilized repurchased shares will be cancelled. The program will be valid for a period of 12 months.